retatrutide clinical trials obesity efficacy (RETA) is one of the most promising investigational peptides in research— Eli Lilly infiltrates anti-obesity market

SURPASS Clinical Trial Program The SURPASS clinical trial [5] program evaluated the efficacy and safety of tirzepatide in individuals with type 2 diabetes

If you may benefit from the medication, your provider will help you decide whether injectable or semaglutide sublingual drops may suit your needs better

doi: 10.1172/JCI196346

The rate of metabolic bariatric surgery decreased from 2022 to 2023, whereas the use of GLP-1 receptor agonists as anti-obesity medications grew over twofold, a research letter showed

How to Manage Reflux Eat smaller meals

These same states report obesity rates near or above 40%, among the highest in the country